Cephalon Files 3rd Suit Over Planned Generic Nuvigil
The number of generics makers sued by Cephalon Inc. for planning to create allegedly infringing generic versions of its narcolepsy drug Nuvigil has climbed to three, now that Mylan Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article